Jushi Holdings (JUSHF) Revenue (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Revenue came in at $66.4 million in Q1 2026, up 4.05% year-on-year from $63.8 million in Q1 2025, and down 2.79% on a QoQ basis from $68.3 million in Q4 2025.
Jushi Holdings (JUSHF) Revenue (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Revenue data on file, last reported at $66.4 million in Q1 2026.
- On a quarterly basis, Revenue rose 4.05% year-over-year to $66.4 million in Q1 2026; TTM through Mar 2026 was $265.5 million, a 3.74% increase from a year earlier, with the FY2025 full-year figure at $262.9 million, up 2.09% from the prior year.
- Revenue for Q1 2026 stood at $66.4 million, down from $68.3 million in the prior quarter.
- Over the last five years, Revenue for JUSHF reached as high as $76.8 million in Q4 2022 and fell as low as $61.6 million in Q3 2024.
- Historically, Revenue has averaged $67.1 million across 5 years, with a median of $65.9 million in 2024.
- Across the five-year window, Revenue soared 52.39% in 2022 and retreated 11.78% in 2023, its largest moves.
- Year by year, Revenue stood at $76.8 million in 2022, then retreated by 11.78% to $67.8 million in 2023, then decreased by 2.82% to $65.9 million in 2024, then increased by 3.76% to $68.3 million in 2025, then declined by 2.79% to $66.4 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $66.4 million in Q1 2026, $68.3 million in Q4 2025, and $65.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Jushi Holdings | 79.96 Mn | 40.26 Mn | 29.88 Mn | 66.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.43 Mn |
| Dec 31, 2025 | 68.34 Mn |
| Sep 30, 2025 | 65.68 Mn |
| Jun 30, 2025 | 65.05 Mn |
| Mar 31, 2025 | 63.85 Mn |
| Dec 31, 2024 | 65.86 Mn |
| Sep 30, 2024 | 61.61 Mn |
| Jun 30, 2024 | 64.60 Mn |
| Mar 31, 2024 | 65.46 Mn |
| Dec 31, 2023 | 67.77 Mn |
| Sep 30, 2023 | 65.38 Mn |
| Jun 30, 2023 | 66.43 Mn |
| Mar 31, 2023 | 69.87 Mn |
| Dec 31, 2022 | 76.82 Mn |
| Sep 30, 2022 | 72.82 Mn |
| Jun 30, 2022 | 72.76 Mn |
| Mar 31, 2022 | 61.89 Mn |
| Dec 31, 2021 | 65.89 Mn |
| Sep 30, 2021 | 53.98 Mn |
| Jun 30, 2021 | 47.74 Mn |